Search results
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) insiders placed bullish bets worth US$1.6m in the last 12...
Simply Wall St. via Yahoo Finance· 1 year agoQuite a few insiders have dramatically grown their holdings in Tarsus Pharmaceuticals, Inc....
The Chief Medical Advisor & Director of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), Elizabeth Lin,...
Simply Wall St. via Yahoo Finance· 2 years agoPotential Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) shareholders may wish to note that the Chief...
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 1 month agoTarsus Pharmaceuticals (TARS) delivered earnings and revenue surprises of 12.17% and 53.97%,...
Tarsus Pharmaceuticals (TARS) Upgraded to Buy: Here's Why
Zacks via Yahoo Finance· 2 months agoTarsus Pharmaceuticals (TARS) might move higher on growing optimism about its earnings prospects,...
Recent uptick might appease Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) institutional owners after...
Simply Wall St. via Yahoo Finance· 7 months agoKey Insights Institutions' substantial holdings in Tarsus Pharmaceuticals implies that they have...
This Tarsus Pharmaceuticals Insider Increased Their Holding In The Last Year
Simply Wall St. via Yahoo Finance· 10 months agoViewing insider transactions for Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS ) over the last year,...
Boyne City's Tarsi caps program-changing career with PNR Player of the Year honor
Petoskey News Review via Yahoo Sports· 6 months agoBoyne City's Ava Tarsi set out to better the Rambler volleyball program when she started out. Four...
Tarsus Pharmaceuticals Inc (TARS) Reports Robust Q4 and Full-Year 2023 Financial Results
GuruFocus.com via Yahoo Finance· 3 months agoQ4 Revenue: $13.1 million from XDEMVY net product sales. Full-Year Revenue: $17.4 million, primarily...
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported Annual Earnings And Analysts Are Lifting...
Simply Wall St. via Yahoo Finance· 3 months agoTarsus Pharmaceuticals, Inc. (NASDAQ:TARS) defied analyst predictions to release its full-year...
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Is Expected To Breakeven In The Near Future
Simply Wall St. via Yahoo Finance· 1 year agoWe feel now is a pretty good time to analyse Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) business...